Potential therapeutic drugs for novel coronavirus pneumonia
The novel coronavirus pneumonia (COVID-19) is still in a serious situation. There is no specific therapeutic drug for COVID-19. At present, drugs, including lopinavir/ritonavir, chloroquine phosphate, abidol, IFN-α atomization and ribavirin, are commonly used in clinical practice. However, further clinical trials are needed to evaluate the efficacy and safety of these drugs. Other potential drugs that may be effective for COVID-19, are worthy of attention, including IL-6 monoclonal antibody, tyrosine protein kinase 1/2 inhibitor, cell therapy drugs, etc. This paper reviews these potential therapeutic drugs for COVID-19.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases - 43(2020), 11 vom: 12. Nov., Seite 970-974 |
| Sprache: |
Chinesisch |
|---|
| Beteiligte Personen: |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.11.2020 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3760/cma.j.cn112147-20200226-00191 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317061984 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317061984 | ||
| 003 | DE-627 | ||
| 005 | 20231225162435.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||chi c | ||
| 024 | 7 | |a 10.3760/cma.j.cn112147-20200226-00191 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1056.xml |
| 035 | |a (DE-627)NLM317061984 | ||
| 035 | |a (NLM)33137863 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a chi | ||
| 100 | 1 | |a Nie, N F |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potential therapeutic drugs for novel coronavirus pneumonia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.11.2020 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The novel coronavirus pneumonia (COVID-19) is still in a serious situation. There is no specific therapeutic drug for COVID-19. At present, drugs, including lopinavir/ritonavir, chloroquine phosphate, abidol, IFN-α atomization and ribavirin, are commonly used in clinical practice. However, further clinical trials are needed to evaluate the efficacy and safety of these drugs. Other potential drugs that may be effective for COVID-19, are worthy of attention, including IL-6 monoclonal antibody, tyrosine protein kinase 1/2 inhibitor, cell therapy drugs, etc. This paper reviews these potential therapeutic drugs for COVID-19 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 700 | 1 | |a He, Y |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases |d 1989 |g 43(2020), 11 vom: 12. Nov., Seite 970-974 |w (DE-627)NLM012624357 |x 1001-0939 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2020 |g number:11 |g day:12 |g month:11 |g pages:970-974 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3760/cma.j.cn112147-20200226-00191 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2020 |e 11 |b 12 |c 11 |h 970-974 | ||